Cargando…
Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: A systematic review
BACKGROUND: Immune-mediated demyelination and consequent degeneration of oligodendrocytes and axons are hallmark features of multiple sclerosis (MS). Remyelination declines in progressive MS, causing permanent axonal loss and irreversible disabilities. Strategies aimed at enhancing remyelination are...
Autores principales: | Allanach, Jessica R, Farrell, John W., Mésidor, Miceline, Karimi-Abdolrezaee, Soheila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688986/ https://www.ncbi.nlm.nih.gov/pubmed/33870797 http://dx.doi.org/10.1177/13524585211008760 |
Ejemplares similares
-
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020
por: Huntemann, Niklas, et al.
Publicado: (2021) -
Current knowledge on the neuroprotective and neuroregenerative properties of citicoline in acute ischemic stroke
por: Martynov, Mikhail Yu, et al.
Publicado: (2015) -
Emerging role of neuregulin-1beta1 in pathogenesis and progression of multiple sclerosis
por: Ziaee, Seyyed Mohyeddin, et al.
Publicado: (2022) -
Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system
por: Grüter, Thomas, et al.
Publicado: (2023) -
Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury
por: Salgado, Iris K., et al.
Publicado: (2015)